Pre-Clinical Development of a Potent Neutralizing Antibody MW3321 With Extensive SARS-CoV-2 Variants Coverage

• প্রধান লেখক: Wen Jiang (লেখক), Zherui Zhang (লেখক), Yuhe Zhu (লেখক), Ben Chen (লেখক), Chunying Gu (লেখক), Zhiyan Liu (লেখক), Xukai Zhang (লেখক), Hualong Xiong (লেখক), Yanan Zhang (লেখক), Bin Zheng (লেখক), Rongjuan Wang (লেখক), Shasha Jiao (লেখক), An Wang (লেখক), Tianying Zhang (লেখক), Jinchao Zhang (লেখক), Shuang Wang (লেখক), Bo Zhang (লেখক), Gang Li (লেখক), Xun Gui (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, several variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged and have consistently replaced the previous dominant variant. Therapeutics against variants of SARS-CoV-2 are urgently needed. Ide...